Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 009296

Expand all

SERPASIL-APRESOLINE (HYDRALAZINE HYDROCHLORIDE; RESERPINE)
25MG;0.1MG
Marketing Status: Discontinued
Active Ingredient: HYDRALAZINE HYDROCHLORIDE; RESERPINE
Proprietary Name: SERPASIL-APRESOLINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;0.1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N009296
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information
SERPASIL-APRESOLINE (HYDRALAZINE HYDROCHLORIDE; RESERPINE)
50MG;0.2MG
Marketing Status: Discontinued
Active Ingredient: HYDRALAZINE HYDROCHLORIDE; RESERPINE
Proprietary Name: SERPASIL-APRESOLINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG;0.2MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N009296
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English